Connection
Theodore Karrison to Quinolines
This is a "connection" page, showing publications Theodore Karrison has written about Quinolines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.651 |
|
|
|
-
Karrison TG. Estimation of progression-free survival in the randomized discontinuation trial design. J Clin Oncol. 2013 Feb 20; 31(6):814.
Score: 0.462
-
Kochanny SE, Worden FP, Adkins DR, Lim DW, Bauman JE, Wagner SA, Brisson RJ, Karrison TG, Stadler WM, Vokes EE, Seiwert TY. A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Cancer. 2020 05 15; 126(10):2146-2152.
Score: 0.189